| 63.84 0.25 (0.39%) | 10-24 16:00 | |||||||||||||
|
|
| Short term |   |
|||
| Mid term |  |
|||
| Targets | 6-month : | 77.86 | 1-year : | 81.26 |
| Resists | First : | 66.66 | Second : | 69.58 |
| Pivot price | 63.8  |
|||
| Supports | First : | 61.94 | Second : | 51.53 |
| MAs | MA(5) : | 63.81 |
MA(20) : | 64.41 |
| MA(100) : | 68.72 |
MA(250) : | 70.41 |
|
| MACD | MACD : | -1 |
Signal : | -1.2 |
| %K %D | K(14,3) : | 32.3 |
D(3) : | 34 |
| RSI | RSI(14): 43.3 |
|||
| 52-week | High : | 82.48 | Low : | 60.56 |
Price has closed above its short-term moving average. Short-term moving average is currently below mid-term; and below long-term moving average. From the relationship between price and moving averages: This stock is NEUTRAL in short-term; and BEARISH in mid-long term.[ HSIC ] has closed below upper band by 49.2%. Bollinger Bands are 28.3% narrower than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.
| If tomorrow: | Open lower | Open higher |
| High: | 64.13 - 64.37 | 64.37 - 64.56 |
| Low: | 62.83 - 63.13 | 63.13 - 63.38 |
| Close: | 63.39 - 63.85 | 63.85 - 64.23 |
Henry Schein, Inc. provides health care products and services to dental practitioners and laboratories, physician practices, government, institutional health care clinics, and other alternate care clinics worldwide. It operates through two segments, Health Care Distribution, and Technology and Value-Added Services. The Health Care Distribution segment offers dental products, including infection-control products, handpieces, preventatives, impression materials, composites, anesthetics, teeth, dental implants, gypsum, acrylics, articulators, abrasives, dental chairs, delivery units and lights, X-ray supplies and equipment, personal protective equipment, and high-tech and digital restoration equipment, as well as equipment repair services. This segment also provides medical products comprising branded and generic pharmaceuticals, vaccines, surgical products, diagnostic tests, infection-control products, X-ray products, equipment, and vitamins. The Technology and Value-Added Services segment offers software, technology, and other value-added services that include practice management software systems for dental and medical practitioners. This segment also provides value-added practice solutions, which comprise financial services on a non-recourse basis, e-services, practice technology, network, and hardware services, as well as continuing education services for practitioners, and consulting and other services. Henry Schein, Inc. was founded in 1932 and is headquartered in Melville, New York.
Thu, 23 Oct 2025
Here's How Henry Schein Is Placed Ahead of Q3 Earnings - sharewise.com
Wed, 22 Oct 2025
HSIC: Barrington Research Maintains Outperform Rating and Price Target | HSIC Stock News - GuruFocus
Wed, 22 Oct 2025
Henry Schein to Participate in Upcoming Investor Conferences in November - Business Wire
Tue, 21 Oct 2025
Earnings Preview: What to Expect From Henry Schein’s Report - Yahoo Finance
Sat, 18 Oct 2025
Henry Schein (HSIC): Evaluating Valuation After New Biomerica Deal and Analyst Downgrade - Sahm
Mon, 06 Oct 2025
July 2026 Options Now Available For Henry Schein (HSIC) - Nasdaq
| Price to Book Value: P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly. |
Neutral |
| Price to Earnings: PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS). |
Neutral |
| Discounted cash flow: DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows. |
Outperform |
| Return on Assets: ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit. |
Outperform |
| Return on Equity: ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency. |
Neutral |
| Debt to Equity: evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn. |
Underperform |
|
Exchange:
NASDAQ
|
|
|
Sector:
Healthcare
|
|
|
Industry:
Medical - Distribution
|
|
| Shares Out | 121 (M) |
| Shares Float | 102 (M) |
| Held by Insiders | 0.8 (%) |
| Held by Institutions | 113.8 (%) |
| Shares Short | 8,860 (K) |
| Shares Short P.Month | 8,600 (K) |
| EPS | 3.1 |
| EPS Est Next Qtrly | 0 |
| EPS Est This Year | 0 |
| EPS Est Next Year | 0 |
| Book Value (p.s.) | 28.26 |
| Profit Margin | 3 % |
| Operating Margin | 5.4 % |
| Return on Assets (ttm) | 4.3 % |
| Return on Equity (ttm) | 8.1 % |
| Qtrly Rev. Growth | 3.2 % |
| Gross Profit (p.s.) | 32.98 |
| Sales Per Share | 105.3 |
| EBITDA (p.s.) | 8.22 |
| Qtrly Earnings Growth | -12.5 % |
| Operating Cash Flow | 512 (M) |
| Levered Free Cash Flow | 333 (M) |
| PE Ratio | 20.52 |
| PEG Ratio | 0 |
| Price to Book value | 2.25 |
| Price to Sales | 0.6 |
| Price to Cash Flow | 15.12 |
| Dividend | 0 |
| Forward Dividend | 0 |
| Dividend Yield | 0% |
| Dividend Pay Date | Invalid DateTime. |
| Ex-Dividend Date | Invalid DateTime. |
|
|
|
|
|
|
|
|
|